Fertility | Managing Depression, Pain, Fatigue | Pancreatic Cancer Blood Test, 05/22/2024

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Fertility Issues in Young People and Adults with Cancer
female doctor speaks with young woman   Learn how cancer treatment can affect fertility and ways that fertility can be preserved. The updated pages Fertility Issues in Girls and Women and Fertility Issues in Boys and Men also include sample questions to ask your doctor and tips on how to find financial resources and clinical trials.
New Approach May Help People with Cancer Better Manage Depression, Pain, and Fatigue
middle aged woman speaks with a health care provider on her laptop   People with cancer who have depression, pain, and fatigue are often referred to providers for treatment and must follow up to make an appointment. A recent study showed that integrating the assessment and treatment of symptoms as part of routine care may help them better manage these problems.

Read More
Blood Test Detects Early Pancreatic Cancer
3 circles (exomes) each with structures inside that look like eyelashes. The eyelash-like structures are labeled mRNA.   In a new study involving nearly 1,000 people, a liquid biopsy accurately detected early- and late-stage pancreatic cancer. When paired with a test for the protein CA19-9, the combination accurately identified 97% of people with early-stage disease.

Read More
Targeted Therapy Approved for Lung Cancer

The Food and Drug Administration (FDA) has approved the targeted therapy alectinib for ALK-positive non-small cell lung cancer. Results from a large clinical trial showed that those treated with alectinib after surgery lived longer without their cancer coming back than those treated with chemotherapy, the current standard treatment. 

Read More

Tovorafenib Approved for Brain Tumors in Children

FDA has approved the targeted therapy tovorafenib (Ojemda) for children aged 6 months and older who have a type of brain tumor called glioma. This approval is for slow-growing (low-grade) tumors that have an abnormal BRAF gene and have come back or did not respond to other treatment.

Read More

 
Contact Us
Cancer Information Specialist talks on a headset   Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.